Skip to main content

Best Biotech Stocks 2024

Discover investment opportunities in Best Biotech Stocks 2024 using our Smart AI Filter.

9 stocks found for "Best Biotech Stocks 2024"
MRNA
Moderna Inc.
Expected returns
Sharpe Ratio
0.83
Beta
±70.5%
Volatility
—
P/E
—
Dividend Yield
BIIB
Biogen Inc.
Expected returns
Sharpe Ratio
0.34
Beta
±25.2%
Volatility
8.0
P/E
—
Dividend Yield
CRSP
Crispr Therapeutics AG
Expected returns
Sharpe Ratio
1.34
Beta
±55.5%
Volatility
—
P/E
—
Dividend Yield
AMGN
Amgen Inc.
Expected returns
Sharpe Ratio
0.45
Beta
±25.0%
Volatility
14.4
P/E
—
Dividend Yield
BMY
Bristol-Myers Squibb Company
Expected returns
Sharpe Ratio
0.35
Beta
±28.9%
Volatility
6.7
P/E
—
Dividend Yield
GILD
Gilead Sciences, Inc.
Expected returns
Sharpe Ratio
0.22
Beta
±27.3%
Volatility
15.0
P/E
—
Dividend Yield
VRTX
Vertex Pharmaceuticals Inc.
Expected returns
Sharpe Ratio
0.36
Beta
±26.9%
Volatility
24.5
P/E
—
Dividend Yield
ILMN
Illumina, Inc.
Expected returns
Sharpe Ratio
0.89
Beta
±41.9%
Volatility
22.8
P/E
—
Dividend Yield
REGN
Regeneron Pharmaceuticals, Inc.
Expected returns
Sharpe Ratio
0.30
Beta
±26.0%
Volatility
12.1
P/E
—
Dividend Yield
About This Search

This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.

Pricing info last updated July 22, 2025(after market close)Other info last updated July 14, 2025

Unlock Advanced Stock Screening

Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.

Save custom stock screens to drafts
Get personalized stock recommendations
Access unlimited screening results
Sign up for free

Compliance disclosure:

The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.